P04.65 Towards new therapies for glioblastoma treatment: role of Dkk-3 and Claudin-5

BACKGROUND: Glioblastomas (GBM) are highly aggressive brain tumors commonly treated with a combination of surgery, radiation therapy, and systemic chemotherapy. However, despite recent improvement in the multimodality approach, patient median survival times range between 3 and 30 months. New data by...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: Caffo, M, Esposito, E, Casili, G, Barresi, V, Caruso, G, Lanza, M, Gorgoglione, N, Germanò, A, Cuzzocrea, S, Cardali, S M
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2018
主題:
Poster Presentations
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144314/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.299
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料